You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

TENORETIC 100 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Tenoretic 100 patents expire, and what generic alternatives are available?

Tenoretic 100 is a drug marketed by Twi Pharms and is included in one NDA.

The generic ingredient in TENORETIC 100 is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tenoretic 100

A generic version of TENORETIC 100 was approved as atenolol; chlorthalidone by TWI PHARMS on May 31st, 1990.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TENORETIC 100?
  • What are the global sales for TENORETIC 100?
  • What is Average Wholesale Price for TENORETIC 100?
Summary for TENORETIC 100
Drug patent expirations by year for TENORETIC 100
Pharmacology for TENORETIC 100

US Patents and Regulatory Information for TENORETIC 100

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Twi Pharms TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TENORETIC 100

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Twi Pharms TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 ⤷  Sign Up ⤷  Sign Up
Twi Pharms TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 ⤷  Sign Up ⤷  Sign Up
Twi Pharms TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TENORETIC 100

See the table below for patents covering TENORETIC 100 around the world.

Country Patent Number Title Estimated Expiration
Yugoslavia 193475 ⤷  Sign Up
Norway 128653 ⤷  Sign Up
South Africa 7207789 ⤷  Sign Up
Israel 33931 3-ALKYLAMINO-1-PHENOXY-2-PROPANOL DERIVATIVES ⤷  Sign Up
Czechoslovakia 153066 ZPUSOB VYROBY FENOXYPROBANOLAMINUZ ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.